BETHESDA, Md.--(BUSINESS WIRE)--Healthnostics, Inc. (OTC:HNSO), a medical and biotechnology analytics information and technology company, announced it is increasing shareholders’ equity by eliminating all long-term debt. An infusion of $250,000 from Chairman and CFO Michael Black in exchange for 25 million shares of HNSO stock that is subject to Rule 144 which Mr. Black purchased at a premium to market, settled the $800,000 debt.
